Thank you for Registering for the Next-Generation Conjugates Summit!

Thank you for registering. You will shortly be receiving an automatic email confirming your online registration and within the next 24 hours, you will receive your invoice and/or payment confirmation. We look forward to welcoming you to the conference.

If you have any questions about your registration, please contact

Telephone: +44 (0)20 3141 8700

Email: customersupport@hansonwade.com

Room Block Available

We are pleased to announce that for the 3rd Next-Generation Conjugates Summit 2024, we have a dedicated room block at the conference hotel, Hotel Commonwealth.

We have discounted nightly rate of $179++ from Sunday February 25 to Tuesday February 27 and a few dates either side.

Hotel CommonWealth

Book Your Room

BOOK VIA WEBSITE HERE

The booking contact number is +1 866 784 4000 (United States and Canada) or +1 617 532 5019.
The contact email is allreservations@hotelcommonwealth.com. Please refer to the name of the event '3rd Next-Generation Conjugates Summit 2024' when you call or email.

Reservations must be made by Friday January 26. However, please note rooms may sell out before the cut-off date due to high demand so we do recommend you book your accommodation sooner rather than later.

Hotel-Commonwealth-Boston-Exterior

 

ADCs & Engineered Antibodies


Maximizing the Therapeutic Window of ADCs & Engineered Antibodies

Conferences

The World ADC Series covers the full breadth and depth of drug conjugates from next-generation conjugates and ADC target selection to ADC analytical development and manufacturing. Our mission is to provide the industry with knowledge and connections to maximize the therapeutic window of drug conjugates. 

Data 

A manually curated database solution including clinical trials and drug records for preclinical, active, approved and discontinued drugs and treatments developed in partnership with the world's leading ADC drug developers and academics.

Research

A trusted provider of market intelligence for anyone looking to understand the complexities of ADC and Engineered Antibodies research and development.